Advertisement
Screener

Eagle Pharmaceuticals, Inc. Proceeds from Common Stock Issued

Eagle Pharmaceuticals, Inc. Proceeds from Common Stock Issued

Eagle Pharmaceuticals, Inc. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-26.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2018-02-26

  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2016-12-31 was $0.00.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2016-09-30 was $0.00.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2016-06-30 was $0.00.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2015 was $54.33M.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2014 was $0.00.
  • Eagle Pharmaceuticals, Inc. proceeds from issuance of common stock for fiscal 2013 was $0.00.
Period endProceeds from Issuance of Common Stock 3 monthProceeds from Issuance of Common Stock 6 monthProceeds from Issuance of Common Stock 9 monthProceeds from Issuance of Common Stock 12 monthProceeds from Issuance of Common Stock 12 month as first filed
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$0.00
derived: sum of 2 quarters · filed 2018-02-26
$0.00
derived: sum of 3 quarters · filed 2018-02-26
$0.00
10-K · filed 2018-02-26
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$0.00
derived: sum of 2 quarters · filed 2016-11-09
$0.00
10-Q · filed 2016-11-09
$0.00
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$0.00
10-Q · filed 2016-08-09
$0.00
derived: sum of 3 quarters · filed 2018-02-26
$0.00
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$0.00
10-Q · filed 2016-05-10
$0.00
derived: sum of 2 quarters · filed 2018-02-26
$0.00
derived: sum of 3 quarters · filed 2018-02-26
-$365.00K
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$0.00
derived: sum of 2 quarters · filed 2018-02-26
-$365.00K
derived: sum of 3 quarters · filed 2018-02-26
$54.33M
10-K · filed 2018-02-26
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$365.00K
derived: sum of 2 quarters · filed 2016-11-09
$54.33M
10-Q · filed 2016-11-09
$54.33M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$365.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$54.33M
10-Q · filed 2016-08-09
$54.33M
derived: sum of 3 quarters · filed 2017-03-15
$8.26M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$54.70M
10-Q · filed 2016-05-10
$54.70M
derived: sum of 2 quarters · filed 2017-03-15
$8.63M
derived: sum of 3 quarters · filed 2017-03-15
$8.21M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$0.00
10-K · filed 2017-03-15
-$46.07M
derived: sum of 2 quarters · filed 2017-03-15
-$46.49M
derived: sum of 3 quarters · filed 2017-03-15
2014-09-30-$46.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$46.49M
derived: sum of 2 quarters · filed 2017-03-15
$0.00
10-K · filed 2017-03-15
$46.07M
10-K · filed 2014-12-22
2014-06-30-$418.23K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-11
$46.07M
10-Q · filed 2014-08-11
2014-03-31$46.49M
10-Q · filed 2014-05-15
2013-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$0.00
10-K · filed 2016-02-29
2013-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-11
$0.00
10-Q · filed 2014-08-11
2013-03-31$0.00
10-Q · filed 2014-05-15
2012-09-30$0.00
10-K · filed 2014-12-22